For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Scientific Program

FP211

2292

Dr.Pooja Mayurbhai Khamar
Membership No Author Name Email Mobile
2292 Dr.Pooja Mayurbhai Khamar dr.poojakhamar@gmail.com 9742272111
Refractive Surgery

Ectasia After Refractive Surgery: Is LOX the Missing Biomarker?

Purpose: To determine if reduced Lysyl Oxidase (LOX) expression predicts ectasia despite normal preoperative topography and biomechanics. 
Methods: From a 12-year biorepository of 3,000+ lenticules, 6 ectasia cases were identified and analysed for LOX expression and genetic variants along with 12 controls. Prospectively, 210 lenticule extraction eyes underwent tear LOX assay; extracted lenticules were preserved and analysed. Low-LOX eyes received PRK (Photorefractive Keratectomy), or ICL (Implantable Collamer Lens). 
Results: All ectasia cases showed reduced LOX and COL1A1 despite normal topography and biomechanics. 65 low-LOX eyes received PRK, or ICL; CBI and SP-A1 correlated with LOX (p<0.05). At 5 years, treated eyes remained stable without ectatic progression. 
Conclusion: Reduced LOX and collagen, identifiable preoperatively, may predict ectasia risk despite normal screening. Tear LOX assay enables personalized risk stratification and targeted prophylactic intervention.

Membership No Author Name Email Mobile
865 Prof.Rohit Shetty drrohitshetty@yahoo.com 9611102568